{"id":"NCT00309777","sponsor":"Kowa Research Europe","briefTitle":"Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin","officialTitle":"Study of Pitavastatin Vs. Simvastatin (Following Up-Titration) in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-09","primaryCompletion":"2006-10","completion":"2006-10","firstPosted":"2006-04-03","resultsPosted":"2009-12-16","lastUpdate":"2010-01-12"},"enrollment":857,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia","Dyslipidemia"],"interventions":[{"type":"DRUG","name":"Pitavastatin","otherNames":[]},{"type":"DRUG","name":"Simvastatin","otherNames":[]}],"arms":[{"label":"Pitavastatin 2 mg","type":"EXPERIMENTAL"},{"label":"Simvastatin 20 mg","type":"ACTIVE_COMPARATOR"},{"label":"Pitavastatin 4 mg","type":"EXPERIMENTAL"},{"label":"Simvastatin 40 mg","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the efficacy and safety of pitavastatin with that of simvastatin.","primaryOutcome":{"measure":"Percent Change From Baseline in Low Density Lipoprotein-cholesterol (LDL-C) at 12 Weeks","timeFrame":"Baseline to 12 weeks","effectByArm":[{"arm":"Pitavastatin 2 mg","deltaMin":-38.99,"sd":14.573},{"arm":"Simvastatin 20 mg","deltaMin":-34.97,"sd":15.528},{"arm":"Pitavastatin 4 mg","deltaMin":-43.97,"sd":14.494},{"arm":"Simvastatin 40 mg","deltaMin":-42.84,"sd":15.769}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":6},"locations":{"siteCount":42,"countries":["Finland","Italy","Norway","Russia","United Kingdom"]},"refs":{"pmids":["19785568"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":311},"commonTop":["Headache","Myalgia","Diarrhea","Back pain","Nausea"]}}